Elavi Labs Shares Are Trading Higher After the Company Announced the Launch of Elevai Biosciences and Elevai Skincare. Also, the Company Announced Results From Its Licensor's 2022 Preclinical Studies Evaluating the Treatment Effect of EL-22
在该公司宣布推出Elevai Biosciences和Elevai Skincare之后,该公司股价走高。此外,该公司还公布了其许可方2022年评估 EL-22 治疗效果的临床前研究结果